Biblio Discovery — Demo Discovery Service

6 results for "Peng, Li-Ming"

Showing 1–6 · 0.21 seconds · RSS

  1. Journal Article Full text

    Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future

    Li, Mo-Yun; Peng, Li-Ming; Chen, Xiao-Ping

    Front Cardiovasc Med · 2022 · English · PubMed Central

    Drug-induced cardiotoxicity (DICT) is an important concern of drug safety in both drug development and clinical application. The clinical manifestations of DICT include cardiomyopathy, arrhythmia, myocardial ischemia, heart failure, and a series of cardiac structural and functional changes. The…

  2. Journal Article Full text

    CD80 DNA methylation and single-nucleotide polymorphism associated with clopidogrel response: a whole-genome DNA methylation analysis in acute coronary syndrome

    Song, Pei-Yuan; Li, Mu-Peng; Peng, Li-Ming et al.

    Res Pract Thromb Haemost · 2023 · English · PubMed Central

    BACKGROUND: Dual antiplatelet therapy with clopidogrel and aspirin is the primary treatment for patients who undergo percutaneous coronary intervention. However, the interindividual difference in clopidogrel response is remarkable, and high on-treatment platelet reactivity (HTPR) can increase the…

  3. Journal Article Full text

    Basigin rs8259 Polymorphism Confers Decreased Risk of Chronic Heart Failure in a Chinese Population

    Li, Mu-Peng; Hu, Xiao-Lei; Yang, Yong-Long et al.

    Int J Environ Res Public Health · 2017 · English · PubMed Central

    Left ventricular remodeling is an essential risk factor contributing to the pathogenesis of chronic heart failure (CHF). Basigin (BSG) promotes cardiovascular inflammation and myocardial remodeling processes by induction of extracellular matrix metalloproteinases and inflammatory cytokines. BSG…

  4. Journal Article Full text

    Association of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population

    Li, Mu-Peng; Zhang, Yan-Jiao; Hu, Xiao-Lei et al.

    Oncotarget · 2017 · English · PubMed Central

    Pathological cardiac hypertrophy is an independent risk factor for chronic heart failure. Casein kinase-2 interacting protein-1 (CKIP-1) can inhibit pathological cardiac hypertrophy. Therefore, we investigated whether CKIP-1 nonsynonymous polymorphism rs2306235 (Pro21Ala) contributes to risk and…

  5. Journal Article Full text

    Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease

    Li, He; Zhang, Yan-Jiao; Li, Mu-Peng et al.

    Front Pharmacol · 2018 · English · PubMed Central

    Dual antiplatelet treatment with aspirin and clopidogrel is the standard therapy for patients undergoing percutaneous coronary intervention (PCI). However, a portion of patients suffer from clopidogrel resistance (CR) and consequently with recurrence of cardiovascular events. Genetic factors such…

  6. Journal Article Full text

    Influence of GAS5/MicroRNA‐223‐3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease

    Liu, Yan‐Ling; Hu, Xiao‐Lei; Song, Pei‐Yuan et al.

    J Am Heart Assoc · 2021 · English · PubMed Central

    BACKGROUND: Dual antiplatelet therapy based on aspirin and P2Y12 receptor antagonists such as clopidogrel is currently the primary treatment for coronary artery disease (CAD). However, a percentage of patients exhibit clopidogrel resistance, in which genetic factors play vital roles. This study…